Kurzrock R - Search Results

1

T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy.

Miyashita H, Kurzrock R, Bevins NJ, Thangathurai K, Lee S, Pabla S, Nesline M, Glenn ST, Conroy JM, DePietro P, Rubin E, Sicklick JK, Kato S. Miyashita H, et al. Among authors: kurzrock r. NPJ Genom Med. 2023 Aug 8;8(1):19. doi: 10.1038/s41525-023-00359-8. NPJ Genom Med. 2023. PMID: 37553332 Free PMC article.

2

Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase.

Geifman N, Haviv I, Kurzrock R, Rubin E. Geifman N, et al. Among authors: kurzrock r. J Pers Med. 2014 Dec 15;4(4):475-88. doi: 10.3390/jpm4040475. J Pers Med. 2014. PMID: 25563458 Free PMC article.

3

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.

Kato S, Schwaederle M, Daniels GA, Piccioni D, Kesari S, Bazhenova L, Shimabukuro K, Parker BA, Fanta P, Kurzrock R. Kato S, et al. Among authors: kurzrock r. Cell Cycle. 2015;14(8):1252-9. doi: 10.1080/15384101.2015.1014149. Cell Cycle. 2015. PMID: 25695927 Free PMC article.

4

Challenges and perspective of drug repurposing strategies in early phase clinical trials.

Kato S, Moulder SL, Ueno NT, Wheler JJ, Meric-Bernstam F, Kurzrock R, Janku F. Kato S, et al. Among authors: kurzrock r. Oncoscience. 2015 Jun 30;2(6):576-80. doi: 10.18632/oncoscience.173. eCollection 2015. Oncoscience. 2015. PMID: 26244164 Free PMC article.

5

Genomic landscape of salivary gland tumors.

Kato S, Elkin SK, Schwaederle M, Tomson BN, Helsten T, Carter JL, Kurzrock R. Kato S, et al. Among authors: kurzrock r. Oncotarget. 2015 Sep 22;6(28):25631-45. doi: 10.18632/oncotarget.4554. Oncotarget. 2015. PMID: 26247885 Free PMC article.

6

Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.

Sicklick JK, Fanta PT, Shimabukuro K, Kurzrock R. Sicklick JK, et al. Among authors: kurzrock r. Cancer Metastasis Rev. 2016 Jun;35(2):263-75. doi: 10.1007/s10555-016-9602-8. Cancer Metastasis Rev. 2016. PMID: 26857926 Free PMC article. Review.

7

The Conundrum of Genetic "Drivers" in Benign Conditions.

Kato S, Lippman SM, Flaherty KT, Kurzrock R. Kato S, et al. Among authors: kurzrock r. J Natl Cancer Inst. 2016 Apr 7;108(8):djw036. doi: 10.1093/jnci/djw036. Print 2016 Aug. J Natl Cancer Inst. 2016. PMID: 27059373 Free PMC article. Review.

8

Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics.

Helsten T, Kato S, Schwaederle M, Tomson BN, Buys TP, Elkin SK, Carter JL, Kurzrock R. Helsten T, et al. Among authors: kurzrock r. Mol Cancer Ther. 2016 Jul;15(7):1682-90. doi: 10.1158/1535-7163.MCT-16-0071. Epub 2016 May 11. Mol Cancer Ther. 2016. PMID: 27196769

9

Genomic Landscape of Malignant Mesotheliomas.

Kato S, Tomson BN, Buys TP, Elkin SK, Carter JL, Kurzrock R. Kato S, et al. Among authors: kurzrock r. Mol Cancer Ther. 2016 Oct;15(10):2498-2507. doi: 10.1158/1535-7163.MCT-16-0229. Epub 2016 Aug 9. Mol Cancer Ther. 2016. PMID: 27507853

10

RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.

Kato S, Subbiah V, Marchlik E, Elkin SK, Carter JL, Kurzrock R. Kato S, et al. Among authors: kurzrock r. Clin Cancer Res. 2017 Apr 15;23(8):1988-1997. doi: 10.1158/1078-0432.CCR-16-1679. Epub 2016 Sep 28. Clin Cancer Res. 2017. PMID: 27683183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

979 results

Search Page